Urinary Tumor Markers for Bladder and Urothelial Cancers 2.02.12
Excellus BlueCross BlueShield policy 2.02.12 considers urinary tumor markers investigational in the diagnosis, monitoring, or screening for bladder cancers. The current version is effective July 16, 2026, and its most recent change is an annual review with the policy intent unchanged. The codes listed in the policy, including CPT 86294, 86386, 88120 and 88121 and the Category III codes listed under CPT, are marked (E/I) Experimental/Investigational.